U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...

Vizz is the first and only aceclidine-based eye drop to improve near vision in adults with presbyopia. Vizz contracts the ...

Jazz Pharmaceuticals bet $1 billion on the commercial potential of a first-in-class oral imipridone for recurrent H3 K27M-mutant diffuse glioma.

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...

The small molecule drug, acquired by Jazz Pharmaceuticals in its $935 million Chimerix pick-up this spring, is intended for ...

Businesses that sell non-FDA-approved hemp products — from gas stations to wellness stores — received a letter from the ...

A Rankin County teenager’s life-changing medication is being denied approval by the U.S. Food and Drug Administration, leaving him and many others with rare diseases unsure of their futures.

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and ...

The National Football League has banned the use of smelling salts ahead of the 2025 season. The announcement was made via ...